Fig. 2From: In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa Percentage of the 65 multidrug-resistant P. aeruginosa isolates for which combined treatment with 20 mg/L rifampicin reduced the MIC compared to imipenem, meropenem or doripenem aloneBack to article page